1c - Abstract su rivista: [4224] Home page tipologia

Sfoglia
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 21 a 40 di 4.224
Titolo Data di pubblicazione Autore(i) File
Part time e comporto 1997 M.L. Vallauri
Metabolomics and frailty: a "from bench to bedside" approach to atrial fibrillation in older patients 2023 Ricciardi, G; Di Serio, C; Pieraccini, G; Romoli, R; La Marca, G; Marchionni, N; Fumagalli, S
Ranolazine is associated with a reduced incidence of atrial fibrillation in patients with chronic coronary syndrome: the results of a real-world analysis of an Italian population 2023 Fumagalli, S; Dovizio, M; Mazzoni, S; Franci Montorzi, R; Santamaria, E; Fumagalli, C; Degli Esposti, L; Marchionni, N
Effect of perceived and objectively-assessed frailty on outcomes in edoxaban-treated patients with atrial fibrillation: data from the ETNA-AF-Europe 4-year follow-up 2023 Fumagalli, S; Diemberger, I; Bakhai, A; Pecen, L; Lamparter, M; Kirchhof, P; De Caterina, R
17-ΒETA-ESTRADIOL PREVENTS OXIDATIVE STRESS-INDUCED APOPTOSIS IN OSTEOCYTES BY GSTP1-1 OVEREXPRESSION 2017 Domazetovic, V. Fontani, F. Marcucci, G. Iantomasi, T. Brandi, ML. Vincenzini, MT.
Abstracts of the ICARE 2023 77th SIAARTI National Congress 2023 Tommaso Del Santo, Chiara Ghelardini, Giulia Paladini, Alessandro Di Filippo, Gianluca Villa, Gabriele Baldini, Stefano Romagnoli
La casa sospesa. Come un albero 2023 Claudio Zanirato
Electroclinical findings in DUPXQ28 syndrome 2011 A. Peron; A. Vignoli; M. Bellini; L. Ballarati; R. Caselli; C. Bonaglia; D. Giardino; F. La Briola; G. Banderali; M.P. Canevini
Efficacy and safety of docetaxel (D) vs androgen-receptor signaling inhibitors (ARSi) as second-line therapy (Rx) after progression on alternative ARSi as first-line Rx for patients who are elderly (≥75 years old) with metastatic castration-resistant prostate cancer (mCRPC) in a multicenter international database: A SPARTACUSS–Meet-URO 26 study 2023 Gennusa, Vincenzo; Saieva, Calogero; Lee-Ying, Richard M.; Nuzzo, Pier Vitale; Spinelli, Gian Paolo; Zanardi, Elisa; Fotia, Giuseppe; Rossetti, Sabrina; Valenca, Loana Bueno; Patrikidou, Anna; Andrade, Livia; Pereira Mestre, Ricardo; Fornarini, Giuseppe; Procopio, Giuseppe; Santini, Daniele; Sweeney, Christopher; Heng, Daniel Yick Chin; De Giorgi, Ugo; Russo, Antonio; Francini, Edoardo
Clinical outcomes of abiraterone acetate (AA) or enzalutamide (E) as first-line therapy (Rx) for men aged ≥75 with metastatic castration-resistant prostate cancer (mCRPC) according to previous use of docetaxel (D) for metastatic castration-sensitive prostate cancer (mCSPC) in a multicenter international registry: A SPARTACUSS – Meet-URO 26 study 2023 Lee-Ying, Richard M.; Saieva, Calogero; Nuzzo, Pier Vitale; Malgeri, Andrea; Fotia, Giuseppe; Zanardi, Elisa; Rossetti, Sabrina; Valenca, Loana Bueno; Patrikidou, Anna; Modesti, Mikol; Martins Oliveira, Thiago; Pignata, Sandro; Fornarini, Giuseppe; Procopio, Giuseppe; Santini, Daniele; Sweeney, Christopher; Heng, Daniel Yick Chin; De Giorgi, Ugo; Russo, Antonio; Francini, Edoardo
CD3+ tumor-infiltrating lymphocytes (TILs) as prognostic in patients (pts) with stage II colon cancer (CC) not treated with adjuvant chemotherapy (ADJ) 2020 Francini, Edoardo; Ou, Fang-Shu; Lazzi, Stefano; Petrioli, Roberto; Multari, Andrea Giovanni; Pesola, Guido; Messuti, Luciana; Colombo, Elena; Livellara, Virginia; Bazzurri, Serena; Cherri, Sara; Salvatora, Miano; Wolfe, Eric; Alberts, Steven R; Hubbard, Joleen Marie; Yoon, Harry H.; Francini, Guido
Clinical outcomes of abiraterone acetate + prednisone (AA) + bone resorption inhibitors (BRI) versus AA alone as first-line therapy for castration-resistant prostate cancer (CRPC) with bone metastases (BM) in an international multicenter database 2020 Francini, Edoardo; Montagnani, Francesco; Nuzzo, Pier Vitale; Gonzalez-Velez, Miguel; Alimohamed, Nimira S.; Cigliola, Antonio; Moreno, Irene; Rubio, Jaime; Crivelli, Francesca; Shaw, Grace; Petrioli, Roberto; Bengala, Carmelo; Francini, Guido; Foncillas, Jesus Garcia; Sweeney, Christopher; Higano, Celestia S.; Bryce, Alan Haruo; Harshman, Lauren Christine; Lee-Ying, Richard; Heng, Daniel Yick Chin
GOLFIG chemo-immunotherapy in metastatic colorectal cancer (mCRC) patients: A fifteen year retrospective analysis 2019 Edoardo Francini
Efficacy of bone resorption inhibitors (BRI) plus abiraterone acetate plus prednisone (AA) vs. AA alone as first-line therapy for men with castration-resistant prostate cancer (CRPC) and bone metastases (BM) in an international multicenter hospital-based registry 2019 Francini, E; Montagnani, F; Vitale, NP; Alimohamed, NS; Candilejo, IM; Rosellini, P; Gonzalez-Velez, M; Rubio, J; Zhang, L; Shaw, G; Crivelli, F; Petrioli, R; Bengala, C; Francini, G; Foncillas, JG; Bryce, AH; Sweeney, C; Harshman, LC; Lee-Ying, R; Heng, DYC
Circulating-free DNA (cfDNA) as biomarker of taxane resistance in metastatic castration-resistant prostate cancer (mCRPC) 2020 Edoardo Francini; Fang-Shu Ou; Justin Rhoades; Eric G. Wolfe; Edward O'Connor; Gavin Ha; Gydush Gregory; Kaitlin Kelleher; Rupal Satish Bhatt; Steven P. Balk; Christopher Sweeney; Viktor Adalsteinsson; Mary-Ellen Taplin; Atish Dipankar Choudhury
Clinical outcomes of sunitinib (Su) for patients (pts) with desmoid tumors (DT) 2019 Miano, Salvatora tindara; Francini, Guido; Civitelli, Serenella; Petrioli, Roberto; Francini, Edoardo
Bone targeted therapy and skeletal related events in the era of modern therapies for castration resistant prostate cancer with bone metastases 2018 Zhang, L; Gray, KP; Shaw, G; Evan, C; Francini, E; Sweeney, C
Impact of new systemic therapies on overall survival (OS) of patients (pts) with metastatic castration resistant prostate cancer (mCRPC) in a hospital-based registry 2018 Francini, E; Gray, KP; Shaw, G; Evan, C; Hamid, A; Perry, CE; Kantoff, PW; Taplin, ME; Sweeney, C
Outcomes of Prechemotherapy (preCRx) Abiraterone Acetate (AA) or Enzalutamide (E) for Metastatic Castration-Resistant Prostate Cancer (mCRPC) after ADT + Docetaxel (D) or ADT Alone for Metastatic Hormone Sensitive Prostate Cancer (mHSPC) in a Multi-Institution Hospital-based Registry. 2017 Francini Edoardo
Outcomes of prechemotherapy (pCHT) abiraterone (AA) or enzalutamide (E) for metastatic castration-resistant prostate cancer (mCRPC) after androgen deprivation therapy (ADT) plus docetaxel (D) or ADT alone for metastatic hormone sensitive prostate cancer (mHSPC) in a hospital-based registry 2017 Francini, E; Gray, KP; Evan, C; Kaymakcalan, MD; Shaw, GK; Kantoff, PW; Taplin, ME; Sweeney, C
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 21 a 40 di 4.224
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile

Scopri
Tipologia
  • 1 - Contributo su rivista4224
  • 4 - Contributo in atti di convegno (Proceedings)1
Autore
  • GACCI, MAURO172
  • MINERVINI, ANDREA158
  • MINI, ENRICO125
  • CARINI, MARCO124
  • PAPINI, ANNA MARIA119
  • ZIGNEGO, ANNA LINDA109
  • MARCHIONNI, NICCOLO'104
  • MATUCCI CERINIC, MARCO98
  • MASSACESI, LUCA96
  • MARI, ANDREA92
Data di pubblicazione
  • In corso di stampa1
  • 2020 - 2024263
  • 2010 - 20192015
  • 2000 - 20091342
  • 1990 - 1999501
  • 1980 - 198998
  • 1975 - 19794
Editore
  • EGU General Assembly 20201
  • ELSEVIER SCIENCE INC1
  • European Association for the Study of the Liver1
  • Italian Pharmacol Soc; Dutch Pharmacol Soc1
  • SPRINGER1
Rivista
  • ITALIAN JOURNAL OF ANATOMY AND EMBRYOLOGY175
  • EUROPEAN UROLOGY. SUPPLEMENTS172
  • GEOPHYSICAL RESEARCH ABSTRACTS120
  • EUROPEAN HEART JOURNAL109
  • JOURNAL OF PEPTIDE SCIENCE85
  • ANNALS OF THE RHEUMATIC DISEASES72
  • THE JOURNAL OF UROLOGY69
  • JOURNAL OF HEPATOLOGY67
  • HEPATOLOGY59
  • JOURNAL OF PLANT PATHOLOGY59
Keyword
  • partial nephrectomy47
  • renal cell carcinoma46
  • landslide28
  • Multiple Sclerosis27
  • systemic sclerosis26
  • cellule dendritiche25
  • multiple sclerosis25
  • medical physics24
  • pharmacology23
  • peptide21
Lingua
  • eng2594
  • ita143
  • fre5
  • por1
  • spa1
Accesso al fulltext
  • no fulltext3072
  • reserved688
  • open459
  • partially open5